02/09/2020 – New independent research reveals that masitinib has direct anti-viral activity against the SARS-CoV-2 virus in-vitro and is a promising candidate for treating COVID-19
AB Science
Masitinib and AB8939 – Two compounds with breakthrough mechanism of action
